Related Experiment Videos
Permanent skin replacement using chimeric epithelial cultured sheets comprising xenogeneic and syngeneic
1Laboratoire de Recherche des Grands Brûlés/LOEX, Hôpital du Saint-Sacrement, Chemin Sainte-Foy, Québec, Canada.
Transplantation
|May 15, 1996
Summary
This study shows that chimeric skin grafts, combining mouse and human cells, can regenerate functional skin. The body eliminates foreign cells, leaving behind healthy, regenerated skin for potential therapeutic use.
Area of Science:
- Regenerative Medicine
- Tissue Engineering
- Dermatology
Background:
- Developing methods for permanent skin replacement is crucial for treating extensive skin damage.
- Current skin grafting techniques face challenges with immune rejection and donor site limitations.
Purpose of the Study:
- To evaluate the potential of chimeric xenogeneic-syngeneic graftable sheets for permanent skin replacement.
- To assess the viability and integration of combined mouse (BALB/c) and human keratinocytes in engineered skin grafts.
Main Methods:
- Newborn BALB/c and human keratinocytes were co-cultured in vitro at different ratios (50:50 and 25:75).
- Chimeric sheets were grafted onto BALB/c mice, and the resulting tissue was analyzed histologically and via cell phenotyping at 14 and 30 days post-grafting.
Main Results:
- Histological analysis revealed well-organized epidermis with functional dermoepidermal junctions and secretion of laminin and type IV collagen.
- Cell phenotyping confirmed the presence of only syngeneic (mouse) keratinocytes, indicating passive elimination of xenogeneic (human) cells without complete graft rejection.
- The process involved activation of cellular and humoral immunity, leading to selective elimination of foreign cells.
Conclusions:
- Chimeric culture methods show promise for cutaneous therapies, including congenital nevi, skin ulcers, and burns.
- This approach may reduce the time required for graftable skin production and potentially mitigate immune tolerance issues in transplantation.